ASH2L
ASH2L (ASH2 like, histone lysine methyltransferase complex subunit) is a nuclear transcriptional regulator and a core subunit of histone H3 lysine 4 methyltransferase complexes. It is also known as ASH2, ASH2L1, ASH2L2 and Bre2, and belongs to the WRAD complex group. Browse Assay Genie's current range of ASH2L research reagents below, or read on for the biology behind the target.
ASH2L regulates transcription by helping to recruit histone methyltransferase complexes to gene promoters. It is a component of the Set1/Ash2 histone methyltransferase complex, which specifically methylates lysine 4 of histone H3 (H3K4), but not when the neighbouring lysine 9 is already methylated. As part of the MLL1/MLL complex, it contributes to the methylation and dimethylation of H3K4. In association with RBBP5 and WDR5, ASH2L stimulates the methyltransferase activities of KMT2A, KMT2B, KMT2C, KMT2D, SETD1A and SETD1B. UniProt also notes that it may play a role in haematopoiesis.
The ASH2L gene encodes a nuclear protein that HGNC classifies among the PHD finger proteins and the WRAD complex. Gene annotation describes beta-catenin binding and transcription cis-regulatory region binding activity, and places the protein in the nucleoplasm and at the plasma membrane. It is part of the MLL3/4 complex and the Set1C/COMPASS complex. The mouse ortholog is Ash2l.
NCBI Gene links ASH2L to positive regulation of cell population proliferation, response to oestrogen and transcription initiation-coupled chromatin remodelling, and it acts upstream of or within the DNA damage response. The name derives from the Drosophila gene ash2 (absent, small, or homeotic discs 2), and earlier HGNC names described it as ash2 (absent, small, or homeotic)-like. Researchers studying the ASH2L protein typically do so in the context of H3K4 methylation and the assembly of WRAD-containing complexes.
ASH2L is a core subunit of H3K4 methyltransferase complexes, making it a central subject for studying histone methylation and transcription initiation-coupled chromatin remodelling.
By recruiting methyltransferase complexes to gene promoters, ASH2L helps define how promoter-associated histone marks regulate transcription.
UniProt annotates a possible role for ASH2L in haematopoiesis, linking histone methyltransferase complex function to blood cell development.
ASH2L is implicated in positive regulation of cell proliferation, response to oestrogen and the DNA damage response.
ASH2L is a transcriptional regulator and subunit of Set1/Ash2 and MLL-type histone methyltransferase complexes, which methylate lysine 4 of histone H3. With RBBP5 and WDR5, it stimulates the activity of KMT2A, KMT2B, KMT2C, KMT2D, SETD1A and SETD1B.
ASH2L is also called ASH2, ASH2L1, ASH2L2 and Bre2. UniProt names it Set1/Ash2 histone methyltransferase complex subunit ASH2. Earlier HGNC names were ash2 (absent, small, or homeotic)-like (Drosophila), reflecting its origin in the Drosophila ash2 gene.
A mouse ortholog, Ash2l, is recognised, and the name derives from the Drosophila ash2 gene. The supplied sources describe roles in proliferation, oestrogen response, DNA damage response and possibly haematopoiesis, but give no specific disease association. Check the datasheet of any product for its validated reactivity.
Histone methyltransferases and WRAD complex partners that act with ASH2L in H3K4 methylation.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9UBL3; product specifications from Assay Genie datasheets.